Application Deadline: Friday, May 15, 2020, 5pm EDT
- The Manning Fund for COVID-19 Research is a newly established innovation fund co-managed by the Provost and the VPR offices for supporting research focused on testing, therapies, vaccines, and ways to reopen society.
- The intent of this fund is to support practically oriented research on COVID-19 related topics that can be acted upon and/or preferably has a commercialization potential.
- Examples of desirable outcomes include improved diagnosis and treatment of disease through new medical devices, biomarkers for diagnostics, therapeutic targets and agents, new clinical adoption of existing tools, and innovative tools for the reopening of society.
- Although not required, it is anticipated that most projects will result in new intellectual property, commercial partnerships, or lead to start-ups.
- Deadline for submissions will be May 15.
- Target size of grant: up to $100k per project. Strong budget justification is required.
- Duration: One year maximum from start to submission of the final report. Reallocation of unspent funds are not allowed.
- This is a fast turnaround program. Decisions will be communicated on or before May 29, 2020. If funds are available, another solicitation may be called for in June.
- Proposals will be evaluated based on its intellectual merit, practicality/viability, societal impact, commercialization potential, and qualifications of the researcher/team.
- Any member of the UVA academic community who is eligible to serve independently as PI on sponsored research proposals may apply.
- Eligible investigators may submit more than one proposal.
Submission and Review Process:
Applications should be submitted as a single PDF (may not exceed four pages) of project description including all illustrations. The cover page, budget page including budget justification, a 2-Page CV of all investigators in any standard format (NIH, NSF, and the like), and relevant current funding information do not count towards the four page limit. Use Arial font, 11-point size.
Eligible budget items include salary support for project personnel, supplies, minor equipment items, prototyping expenses, core facility charges, and other well-justified expenses specific to the project. Funds cannot be requested or used for F&A costs, administrative support or tuition. Budgets should not exceed $100,000 in direct costs for a one-year period.
Award recipients are required to submit short written quarterly progress reports and a final report.
Key Elements of the Proposal:
Cover Page: (not included in page limit)
- Must contain the project title, names of the investigators, amount requested, and summary of the novelty and significance of the proposed work, and the approval signature of your school's dean(s). Please contact the Associate Research Dean in your school for coordination.
Project Plan: Research description and commercialization potential (four page limit):
Overall plan: Problem description, current approaches, proposed research, and impact of proposed research, research milestones, and a discussion of commercialization potential.
- Specific research milestones and the research plan for achieving each milestone. Include the experiments to be performed to achieve each milestone; provide supporting preliminary data/hypothesis as appropriate.
- Include IRB and/or ACUC status for project if relevant.
- Current intellectual property status, commercialization potential to advance the technology into the market and/or clinical adoption, the FDA approval plan (if relevant).
- Any plan for follow-on funding after award expires.
Proposal Supporting Documents (not included in page limit)
- 1-page Budget and budget justification (use any format)
- 2-page CV’s of each investigator in any standard format (NIH, NSF, and the like)
- List of relevant current funding and pending proposals for each investigator